The most controversial issue in organ donation
after the circulatory determination of death is whether the donor was truly
dead at the moment death is declared. My colleagues and I further analyzed this
issue by showing the relevance of the distinction between the “permanent” and
the “irreversible” loss of circulatory functions. Permanent cessation means
that circulatory function will not return because it will not be restored
spontaneously and medical attempts to restore it will not be conducted. By
contrast, irreversible cessation means that circulatory function cannot be
restored using currently available technology. In this issue of the Report,
Kevin Munjal and colleagues criticize the unjustified application of the
permanent-irreversible distinction, which my colleagues and I developed for
cDCDD, to their well-designed and carefully conducted experimental protocol of
uncontrolled DCDD (uDCDD) in New York City, for which our analysis was not
targeted. They claimed that to determine a donor’s death in uDCDD, it is
unnecessary to show that permanence is a valid surrogate indicator of
irreversibility because the unsuccessful attempt to resuscitate the patient
comprises prima facie evidence of circulatory irreversibility. Ironically, that
potent justification defending death determination in uDCDD yields limitations
that are similar to those created when our permanent-irreversible distinction
is applied to death determination in cDCDD.
The most controversial issue in organ donation
after the circulatory determination of death is whether the donor was truly
dead at the moment death is declared. My colleagues and I further analyzed this
issue by showing the relevance of the distinction between the “permanent” and
the “irreversible” loss of circulatory functions. Permanent cessation means
that circulatory function will not return because it will not be restored
spontaneously and medical attempts to restore it will not be conducted. By
contrast, irreversible cessation means that circulatory function cannot be
restored using currently available technology. In this issue of the Report,
Kevin Munjal and colleagues criticize the unjustified application of the
permanent-irreversible distinction, which my colleagues and I developed for
cDCDD, to their well-designed and carefully conducted experimental protocol of
uncontrolled DCDD (uDCDD) in New York City, for which our analysis was not
targeted. They claimed that to determine a donor’s death in uDCDD, it is
unnecessary to show that permanence is a valid surrogate indicator of
irreversibility because the unsuccessful attempt to resuscitate the patient
comprises prima facie evidence of circulatory irreversibility. Ironically, that
potent justification defending death determination in uDCDD yields limitations
that are similar to those created when our permanent-irreversible distinction
is applied to death determination in cDCDD.